2BB score and signals
Atea Pharmaceuticals, Inc.’s current 2BB score is 33 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 18 | Very Low |
| Momentum | 39 | Weakening |
| Financial strength | 40 | Normal |
| Quality | 80 | Very Strong |
| Risk | 37 | Low |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 2012 |
| Employees | 55 |
| 52-week range | $2.78 – $6.45 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.4284 | — | $0.00 |
| 2026-08-12 | — | -0.5712 | — | $0.00 |
| 2026-05-12 | -0.57 | -0.6018 | $0.00 | $0.00 |
| 2026-03-03 | — | -0.5406 | — | $0.00 |
Related companies